Optase

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Optase
Generic name
GLYCERIN
Manufacturer
Scope Health Inc
Product type
HUMAN OTC DRUG
SPL set ID
10c3e31d-779d-8ff6-e063-6294a90acd39
SPL ID
5eb20b17-46d0-945d-e063-6394a90ad2ac
Version
6
Effective date
2026-10-25
Source export date
2026-11-13
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/3b4204ed830f35b16ab24b2123672d7d93066eb0fd8af1cf09b223d0e4568221/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 15:31:36
Harmonized routes table
Harmonized routes
OPHTHALMIC

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warning • For external use only. • To avoid contamination, do not touch tip of container to any surface. • If solution changes color or becomes cloudy, do not use. • Do not use a damaged or punctured single-dose container. • Wait at least 15 minutes between possible applications of other ophthalmic medication. • Use immediately once opened. • Do not reuse. Discard any remaining solution after use. • Do not use if you are sensitive to any of the ingredients. • Do not use after the expiry date shown on the pack.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.